QUINCE THERAPEUTICS INC (QNCX) Stock Analyst Ratings
USA - NASDAQ:QNCX - US22053A1079 - Common Stock
1.74 USD
+0.14 (+8.75%)
ChartMill assigns a Buy % Consensus number of 83% to QNCX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.65. This target is 339.66% above the current price.
QNCX was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about QNCX.
In the previous month the buy percentage consensus was at a similar level.
QNCX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-12 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-05 | JMP Securities | Initiate | Market Outperform |
| 2025-07-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-24 | Oppenheimer | Initiate | Outperform |
| 2025-02-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-18 | Brookline Capital | Initiate | Buy |
| 2024-11-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-07 | Maxim Group | Initiate | Buy |
| 2024-10-29 | Rodman & Renshaw | Initiate | Buy |
| 2024-10-22 | EF Hutton | Initiate | Buy |
QUINCE THERAPEUTICS INC / QNCX FAQ
Can you provide the average price target for QUINCE THERAPEUTICS INC stock?
12 analysts have analysed QNCX and the average price target is 7.65 USD. This implies a price increase of 339.66% is expected in the next year compared to the current price of 1.74.
What is the consensus rating for QUINCE THERAPEUTICS INC (QNCX) stock?
The consensus rating for QUINCE THERAPEUTICS INC (QNCX) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for QUINCE THERAPEUTICS INC stock?
The number of analysts covering QUINCE THERAPEUTICS INC (QNCX) is 12.